维普期刊资源整合服务平台（V6.5）

180篇 您的检索式：作者名="Reid IR"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	类固醇性骨质疏松的发病学和治疗显示文摘早在1932年,Cushing就已指出,过量内源性皮质类固醇有增加骨折的倾向。随后10年在使用可的松作为治疗用药后,从椎骨骨折的病例报告中,提示外源性皮质醇过多可使骨受损。此后,许多作者从组织形态学、骨活检、掌骨皮质厚度或骨密度测定,都表明接受类固醇治疗的病人骨块减失。类固醇治疗期间的骨丢失前瞻性研究不多。	Reid IR 徐隆绍	1990	国外医学(内分泌学分册)1990，10，1：	5
2	Differences between the bisphosphonates for the prevention and treatment of osteoporosis显示文摘	Grey A Reid IR	2006	Ther Clin Risk Man-ag2006，2，1：	1
3	Effects of calcium supplementation on bone loss in postmenopausal women 显示文摘	Reid IR Ames RW Evans MC	1993	N Engl J Med1993，328，：	1
4	Effect of calcium supplementation o n bone loss in postmenopausal women显示文摘	Reid IR Ames RW Evans MC	1993	N Engl J Med1993，328，：	1
5	The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) 显示文摘	Black DM Reid IR Boonen S	2012	J Bone Miner Res2012，27，：	1
6	Intravenous zoledronic acid in postmenopausal women with low bone mineral density显示文摘	Reid IR Brown JP Burckhardt P	2002	N Engl J Med2002，346，9：	1
7	Effects of calcium supplementation on circulating lipids:potential pharmacoeconomic implications显示文摘	Reid IR	2004	Drugs Aging2004，21，1：	1
8	Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: aran- domized controlled trial 显示文摘	Reid IR Cundy T	2007	Clin Endocrinol Metab2007，92，：	1
9	The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis:a randomized extension to the HORIZON-Pivotal Fracture Trial(PFT)显示文摘	Black DM Reid IR Boonen S	2012	J Bone Miner Res2012，27，2：	1
10	Once-yearly zoledronic acid for treatment of post-menopausal osteoporosis显示文摘	Black DM Delmas PD Eastell R Reid IR Boonen S Cauley JA Cosman F Lakatos P Leung PC Man Z Mautalen C Mesenbrink P Hu H Caminis J Tong K Rosario-Jansen T Krasnow J Hue TF Sellmeyer D Eriksen EF Cummings SR HORIZON Pivotal Fracture Trial		0，，：	1
11	Hydrochlorothiazidereduces loss of cortical bone in normal postmenopausal women:a randomized controlled trial显示文摘	Reid IR Ames RW Orr-Walker BJ	2000	Am J Med2000，109，5：	1
12	Long-tem effects of calcium supplementation on bone loss and fractures in postmenopausal women a randomized controlled trial显示文摘	Ames RW Evans MC	1995	Am J Med1995，98，4：	1
13	Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid 显示文摘	Reid IR Gamble GD Mesenbrink P	2010	J Clin Endocrinol Metab2010，95，9：	1
14	Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure 显示文摘	Reid IR Gallagher DJ Bosworth J	1986	Age Ageing1986，15，1：	1
15	The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis:a randomized extension to the HORIZON-Pivotal Fracture Trial(PFT)显示文摘	Black DM Reid IR Boonen S Bucci-Rechtweg C Cauley JA Cosman F Cummings SR Hue TF Lippuner K Lakatos P Leung PC Man Z Martinez RL Tan M Ruzycky ME Su G Eastell R		0，，：	1
16	beta-blocker use, BMD, and fractures in the study of osteoporotic fractures 显示文摘	Reid IR Gamble GD Grey AB	2005	J Bone Miner Res2005，20，：	1
17	Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams显示文摘	Reid IR Black DM Eastell R Bucci-Rechtweg C Su G Hue TF Mesenbrink P Lyles KW Boonen S HORIZON Pivotal Fracture Trial and HORIZON Recurrent Fracture Trial Steering Commi-ttees		0，，：	1
18	The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis:a randomized extension to the HORIZON-pivotal fracture trial(PFT)显示文摘	Black DM Reid IR Boonen S	2012	J Bone Miner Res2012，27，2：	1
19	Intravenous zoledronic acid in postmenopausal women with low bone mineral density显示文摘	Reid IR Brown JP Burckhardt P	2002	N EngI J Med2002，346，9：	1
20	The chronic and severe forms of eosinophilic meningitis 显示文摘	Reid IR Wall is WE	1984	Aust N Z J Med1984，14，2：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示